TFR1 is widely expressed and has a higher affinity for TF, while TFR2 is mostly expressed in hepatocytes and erythroid cells, whereas TFR1 has been found to join in the progression of many tumors, such as brain cancer [4], breast cancer [5], and colon cancer [6]. This evidence concerns the gene TFRC and breast cancer.